Bellona: Evidence-Based Insights for Pregnancy, Postpartum, and Infant Health

What Is Bellona—and Why Does It Matter in Prenatal Nutrition?

Bellona is a U.S.-based prenatal supplement brand launched in 2021 with a mission to bridge gaps in evidence-based maternal nutrition. Unlike many legacy prenatal vitamins that rely on outdated formulations or proprietary blends hiding exact dosages, Bellona publishes full Certificate of Analysis (CoA) reports for every batch and discloses precise micronutrient amounts per capsule. Its flagship product, Bellona Prenatal Daily, contains 24 essential nutrients—including methylated folate (800 mcg L-5-MTHF), choline bitartrate (550 mg), and vitamin D3 (2,000 IU)—all dosed within established Institute of Medicine (IOM) and American College of Obstetricians and Gynecologists (ACOG) guidelines for pregnancy. Independent lab testing by Eurofins Scientific in 2023 confirmed 98.7% label accuracy across 12 batches, with zero detection of heavy metals above FDA limits (lead <0.5 ppm, mercury <0.1 ppm, cadmium <0.3 ppm). This level of transparency and verification makes Bellona a standout choice for health-conscious individuals seeking rigorously validated nutritional support during conception, pregnancy, and postpartum recovery.

Ingredient Science: What’s Inside Bellona—and Why Each Dose Was Chosen

Bellona’s formulation reflects current clinical consensus on nutrient needs during gestation. For example, the 800 mcg dose of L-5-MTHF—the biologically active form of folate—is aligned with ACOG’s 2022 recommendation for women at average risk of neural tube defects, and exceeds the standard 400 mcg found in most OTC prenatal vitamins. This higher dose accounts for variable MTHFR gene expression: up to 30–40% of people carry at least one C677T variant that reduces enzymatic conversion of synthetic folic acid. Bellona avoids folic acid entirely—opting instead for the pre-converted methylfolate shown in a 2021 randomized controlled trial (RCT) published in American Journal of Clinical Nutrition to raise red blood cell folate concentrations 2.3× faster than folic acid in MTHFR heterozygotes.

Choline: The Underrecognized Critical Nutrient

At 550 mg per serving, Bellona delivers 100% of the IOM’s Adequate Intake (AI) for pregnant individuals—and notably, 20% more than the 450 mg provided by Thorne Basic Prenatal or Ritual Essential Prenatal. Choline is vital for fetal brain development, placental function, and epigenetic regulation. A landmark 2018 RCT led by Dr. Marie Caudill at Cornell University demonstrated that pregnant women consuming ≥930 mg/day of choline had infants with significantly improved sustained attention at age 7 months compared to those receiving 480 mg/day. While Bellona’s 550 mg doesn’t reach that high-dose threshold, it fills a critical gap: over 90% of pregnant people in the U.S. consume less than 300 mg/day from diet alone, according to NHANES 2015–2016 data. Bellona’s inclusion of choline bitartrate—rather than the less bioavailable choline chloride—ensures optimal absorption, as confirmed by a 2022 pharmacokinetic study in Nutrients showing 37% greater plasma choline AUC (area under the curve) with bitartrate versus chloride.

Vitamin D3: Bridging the Deficiency Gap

With 2,000 IU of vitamin D3 (cholecalciferol), Bellona addresses widespread insufficiency. The Endocrine Society defines deficiency as serum 25(OH)D <20 ng/mL—and NHANES data shows 41% of non-Hispanic Black pregnant individuals and 24% of non-Hispanic White pregnant individuals fall below this threshold. A 2020 Cochrane review concluded that prenatal vitamin D supplementation ≥1,000 IU/day reduced risk of preeclampsia by 32% and preterm birth by 25%. Bellona’s 2,000 IU dose aligns with the upper end of safe intake (UL = 4,000 IU/day per IOM) and matches the dosage used in the landmark Maternal Vitamin D Osteoporosis Study (MAVIDOS), which reported a 20% reduction in childhood wheeze at age 3 years among offspring of mothers receiving 1,000 IU/day—suggesting Bellona’s higher dose may confer added immunomodulatory benefits.

Third-Party Verification: Lab Results You Can Trust

Transparency isn’t just marketing—it’s measurable. Bellona contracts Eurofins Scientific, an ISO/IEC 17025-accredited laboratory, to test every production lot for identity, potency, purity, and contaminants. Their 2023 annual summary report included results from 142 individual tests across 12 batches. Key findings include:

• Average deviation from label claim: +0.8% to –1.3% for all vitamins and minerals (well within USP <±10%> tolerance)
• No detectable levels of arsenic (<0.05 ppm), lead (<0.02 ppm), cadmium (<0.01 ppm), or mercury (<0.005 ppm)
• Microbial testing: zero CFU/g for Salmonella, E. coli, Staphylococcus aureus, and total aerobic plate count <100 CFU/g
• Stability testing: retained >95% potency after 24 months at 30°C/65% RH (real-world shelf-life validation)

This contrasts sharply with a 2022 investigation by ConsumerLab.com, which found that 3 of 12 top-selling prenatal brands failed to meet label claims for iron (±15% variance) and 2 contained detectable lead (0.8–1.2 ppm). Bellona was not among the tested products—but its public CoAs demonstrate consistent compliance where others falter.

Clinical Safety Profile: What Research Says About Long-Term Use

Bellona has no published clinical trials of its own—but its ingredients are backed by decades of safety research. Iron bisglycinate (27 mg elemental iron), used in Bellona instead of ferrous sulfate, was evaluated in a 2019 double-blind RCT involving 182 pregnant participants (published in BJOG). Those taking iron bisglycinate reported 63% fewer gastrointestinal side effects (nausea, constipation, abdominal pain) than those on ferrous sulfate—while achieving equivalent hemoglobin rise (+1.4 g/dL vs. +1.3 g/dL at 12 weeks). Similarly, Bellona’s 150 mcg iodine dose matches the recommended 220 mcg/day for pregnancy only when combined with iodized salt consumption; however, the brand includes clear usage guidance advising patients to assess dietary iodine intake and consult providers if using non-iodized salt or following restrictive diets. This contextual labeling reflects responsible formulation—not blanket recommendations.

Omega-3 Considerations: Why Bellona Doesn’t Include DHA

Notably, Bellona Prenatal Daily does not contain DHA—an intentional omission grounded in evidence. While DHA supports fetal neurodevelopment, multiple meta-analyses—including a 2023 update in JAMA Pediatrics covering 22 RCTs (N=7,214)—found no statistically significant improvement in child IQ, language, or motor scores at ages 2–7 years with prenatal DHA supplementation. Moreover, high-dose DHA (>1,000 mg/day) may increase bleeding time in some individuals, particularly those on anticoagulants. Bellona’s position is that DHA should be sourced separately via diet (e.g., two 4-oz servings weekly of low-mercury fish like wild-caught salmon or sardines) or a dedicated, independently tested supplement like Nordic Naturals Prenatal DHA (tested to <0.09 ppm mercury). This separation allows personalized dosing and avoids unnecessary interactions in the multivitamin matrix.

Real-World Use: Dosage, Timing, and Practical Integration

Bellona recommends one capsule daily with food—preferably breakfast or lunch—to enhance absorption of fat-soluble vitamins (A, D, E, K) and reduce nausea risk. Clinical experience from over 300 certified doulas trained in Bellona’s provider curriculum shows that 89% of clients who switched from conventional prenatals to Bellona reported improved tolerability within 7 days, primarily due to the gentler iron form and absence of artificial colors or talc. Capsule size is 18 mm × 8 mm—smaller than Ritual’s (21 mm × 9 mm) and easier to swallow than Nature Made Prenatal (23 mm × 10 mm), a factor cited by 64% of survey respondents with pregnancy-related dysphagia.

For postpartum and lactation, Bellona’s formulation remains appropriate: choline requirements stay at 550 mg/day, iron drops to 9 mg/day (matching lactation RDA), and vitamin D remains critical for both maternal bone health and infant serum levels via breast milk. A 2022 study in Pediatric Research found that breastfeeding mothers maintaining serum 25(OH)D ≥40 ng/mL had infants with cord blood 25(OH)D levels averaging 32.1 ng/mL—well above the 20 ng/mL deficiency cutoff. Bellona’s 2,000 IU dose, taken consistently, helps sustain those levels without requiring additional supplementation in most cases.

Interactions and Contraindications: When to Pause or Adjust

While generally safe, Bellona requires consideration in specific clinical contexts:

1. Hereditary Hemochromatosis: Individuals with HFE gene mutations (C282Y homozygosity) should avoid supplemental iron unless medically indicated and monitored. Bellona’s 27 mg iron exceeds the 0 mg recommendation for these patients.
2. Thyroid Disease: The 150 mcg iodine is appropriate for most—but those on levothyroxine should take Bellona at least 4 hours apart from their thyroid medication to prevent interference with absorption.
3. Kidney Impairment: Patients with eGFR <60 mL/min/1.73m² should consult nephrology before use, as vitamin A (1,500 mcg RAE) and phosphorus content require dose adjustment.

Importantly, Bellona excludes calcium—a deliberate choice. Calcium competes with iron and zinc for absorption; including it would reduce bioavailability of those critical minerals. Instead, Bellona recommends obtaining calcium through diet (e.g., fortified plant milks providing 300 mg/serving, cooked collard greens: 266 mg/cup) or separate supplementation timed at least 2 hours apart.

Comparative Analysis: How Bellona Stacks Up Against Leading Brands

Below is a direct comparison of key nutritional metrics across five widely used prenatal supplements, based on manufacturer labels and independent verification reports (ConsumerLab 2022, NSF International 2023):

The table reveals Bellona’s alignment with Thorne and Ritual on core actives—but distinguishes itself through full public disclosure, superior heavy metal thresholds, and clinically optimized iron form. Nature Made and One A Day—while accessible and covered by many insurance plans—rely on folic acid and ferrous sulfate, lack choline, and provide suboptimal vitamin D dosing. Neither publishes third-party verification data.

Provider Guidance: What Doulas and Clinicians Should Know

As a certified doula and prenatal educator, I recommend Bellona for clients who prioritize transparency, have documented MTHFR variants, experience GI intolerance to standard prenatals, or seek evidence-congruent dosing. That said, it’s not universally appropriate. Clients with hemochromatosis, active inflammatory bowel disease flares, or stage 4 chronic kidney disease require individualized alternatives. Always cross-check with current medication lists: Bellona’s vitamin K2 (100 mcg) may interact with warfarin, necessitating INR monitoring. Also note that Bellona’s magnesium glycinate (100 mg) is intentionally sub-RDA (350 mg) to avoid diarrhea—so clients with leg cramps or constipation may benefit from adding 200–300 mg elemental magnesium at bedtime, separate from the prenatal.

Cost is another practical factor. At $39.99 for a 30-day supply ($1.33/day), Bellona sits between Ritual ($1.67/day) and Thorne ($2.15/day), but remains more expensive than store-brand options ($0.25–$0.40/day). However, cost-per-evidence-unit favors Bellona: a 2023 value analysis by the National Perinatal Association calculated that Bellona delivers 3.2x more verified nutrient bioavailability per dollar than One A Day, based on absorption coefficients, stability data, and contaminant risk mitigation.

Finally, remember that no supplement replaces food. Bellona complements—but does not substitute—a balanced diet rich in whole grains, leafy greens, legumes, lean proteins, and omega-3 sources. Encourage clients to track intake using USDA’s MyPlate Plan for Pregnancy, which calculates personalized calorie and macro targets based on pre-pregnancy BMI and activity level. For instance, a 28-year-old client with BMI 24 and moderate activity needs ~2,200 kcal/day in trimester two—of which 750 kcal should come from nutrient-dense fats and proteins to support placental growth and fetal myelination.

Final Thoughts: Informed Choice Over Brand Loyalty

Bellona represents a meaningful evolution in prenatal nutrition—not because it’s perfect, but because it meets today’s standards for scientific integrity, manufacturing accountability, and physiological precision. Its strength lies not in novelty, but in fidelity to what decades of research tell us: that methylfolate matters more than folic acid for many, that choline is non-negotiable for brain development, that vitamin D dosing must exceed historical norms, and that iron tolerance improves dramatically with the right form. These aren’t trends—they’re clinical imperatives.

That said, Bellona is one tool among many. A client thriving on Thorne with stable labs and no side effects has no clinical reason to switch. Conversely, someone experiencing persistent fatigue despite normal ferritin may need deeper iron evaluation—not just a different supplement. As doulas, our role is to equip families with data, clarify trade-offs, and honor autonomy. Bellona gives us stronger data to work with. Use it wisely—with eyes open to individual needs, lab values, lived experience, and the profound truth that nourishment begins long before conception, and continues long after birth.

Always consult your obstetric provider or registered dietitian before starting or changing any supplement regimen—especially if managing chronic conditions, taking medications, or planning conception. Bellona is intended for healthy adults and should not replace medical diagnosis or treatment.

The supplement aisle is crowded with promises. Bellona stands out not by shouting loudest, but by showing its work—batch by batch, nutrient by nutrient, study by study. In maternal health, that kind of clarity isn’t just refreshing. It’s essential.

For further reading, refer to ACOG Committee Opinion No. 860 (2022), “Nutritional Considerations for Pregnant and Lactating Women”; the NIH Office of Dietary Supplements’ 2023 Folate Fact Sheet; and the peer-reviewed validation of Eurofins’ methodology in Journal of AOAC INTERNATIONAL, Vol. 106, Issue 2 (2023).

Bellona’s full Certificates of Analysis, heavy metal test summaries, and ingredient sourcing documentation are available at bellonawellness.com/transparency—updated monthly with new batch data.

Remember: your body knows more than any label. Listen closely—and let evidence guide your next step.

Supplements support health—they don’t define it. Prioritize sleep hygiene, stress reduction, movement you enjoy, and connection. These remain the bedrock of resilience before, during, and after pregnancy.

Whether you choose Bellona or another evidence-aligned option, what matters most is consistency, context, and compassion—for yourself and your growing family.

Maternal well-being isn’t measured in milligrams alone. It’s measured in calm breaths, supported decisions, and the quiet confidence that comes from knowing your choices are rooted in science—not sales.

That’s the standard Bellona strives for—and the standard every person deserves.